Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Shares Outstanding (Weighted Average) (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Shares Outstanding (Weighted Average) data on record, last reported at $67.4 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 15.41% year-over-year to $67.4 million; the TTM value through Dec 2025 reached $67.4 million, up 15.41%, while the annual FY2025 figure was $67.4 million, 15.41% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $67.4 million in Q4 2025 per PLSE's latest filing, roughly flat from $67.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $67.4 million in Q4 2025 and bottomed at $26.1 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $46.3 million, with a median of $46.7 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 52.78% in 2024, then rose 10.35% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $28.0 million in 2021, then increased by 21.35% to $33.9 million in 2022, then surged by 46.57% to $49.7 million in 2023, then rose by 17.41% to $58.4 million in 2024, then increased by 15.41% to $67.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $67.4 million in Q4 2025, $67.4 million in Q3 2025, and $67.3 million in Q2 2025.